|
Re: Impact of a chemoresponse assay on treatment costs for recurrent ovarian cancer
You have to wonder why cash strapped NHS or other socialized med arrangements wouldn't want to avoid costly trial and error medicine.
I do wish these sensitivity tests included hormonal, biological and CAM therapies. Chemo aint the only game in town.
|